Astral Systems unlocks £23m Series A led by Mercia Ventures to develop medical isotopes with multi-state fusion technology

Astral Systems is a Bristol-based deep-tech firm that invented and commercialised multi-state fusion technology, a new type of nuclear fusion. Its compact modular reactors produce medical radioisotopes and serve research, medical, and industrial customers facing fragile isotope supply chains.